Site pages
Current course
Participants
General
Topic 1
Topic 2
Topic 3
Topic 4
Topic 5
Topic 6
Topic 7
Topic 8
Topic 9
Topic 10
Topic 11
Topic 12
Topic 13
Topic 14
Topic 15
Topic 16
Topic 17
Topic 18
Topic 19
Topic 20
Topic 21
Topic 22
Topic 23
Topic 24
Topic 25
Topic 26
Topic 27
Topic 28
Topic 29
Topic 30
Topic 31
4.3.15. Conclusion
Recent advances in the field of molecular biology have profoundly affected the development of fish vaccines.
-
Antigens obtained from many fish pathogens with the potential of being used for vaccine have been identified.
-
Gene tically engineered vaccines have been increasingly employed against many of the fish pathogens.
-
DNA vaccine, the most recent of all vaccines have been shown to be highly efficient against some fish viral diseases.
-
Field scale efficacy study of some of these vaccines is being undertaken.
-
Although great efforts have been carried out on the development of efficient vaccines against various fish pathogens, the delivery systems of the vaccine to fish is equally important. One has to make sure that the vaccine can be effectively delivered and it is suitable for intensive aquaculture in terms of cost effectiveness.
-
So far, there is only one recombinant protein vaccine for commercial use in aquaculture, which is against the IPNV of trout.
-
It is expected that some more genetically modified vaccines may be commercialized in the near future.
Last modified: Friday, 29 June 2012, 4:55 AM